Dietary macromolecules in gut lumen

Dietary macromolecules in the gut lumen encompass the primary macronutrients—carbohydrates, lipids, and proteins—ingested through the diet that undergo mechanical and chemical digestion within the gastrointestinal tract (NIH, 2023). These molecules serve as the fundamental building blocks and energy sources for human physiology, but their dysregulated processing or excessive intake is central to metabolic diseases such as obesity and type 2 diabetes (StatPearls, 2023). While not a single molecular target in the traditional pharmacological sense, these macromolecules are the focus of therapeutic interventions aimed at reducing caloric intake or managing metabolic markers. For instance, pharmacological agents like orlistat inhibit the enzymatic breakdown of dietary fats by targeting gastric and pancreatic lipases, while alpha-glucosidase inhibitors like acarbose delay the digestion of complex carbohydrates (PubChem, 2024; PubMed, 2022). Consequently, these interventions prevent the absorption of these macromolecules, leading to their excretion and helping to manage weight and glycemic control, though they often result in gastrointestinal side effects like steatorrhea (Mayo Clinic, 2023).

Other names

Dietary macronutrientsLuminal nutrientsGastrointestinal macromoleculesDietary substrates

Inhibition of digestive enzymes (such as lipases and alpha-glucosidases) or physical sequestration of nutrients to prevent their systemic absorption from the gastrointestinal tract.